| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,237 |
2,099 |
$830K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,537 |
3,344 |
$465K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
643 |
588 |
$397K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
557 |
526 |
$319K |
| 71045 |
Radiologic examination, chest; single view |
662 |
614 |
$43K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,016 |
957 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,173 |
714 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,135 |
1,045 |
$23K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
126 |
25 |
$18K |
| 80053 |
Comprehensive metabolic panel |
2,422 |
2,155 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
492 |
416 |
$13K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
650 |
587 |
$12K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
105 |
103 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,373 |
2,110 |
$11K |
| 87428 |
|
87 |
86 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
420 |
382 |
$4K |
| 76376 |
|
260 |
237 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
120 |
114 |
$2K |
| 81001 |
|
665 |
626 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
42 |
40 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,893 |
3,287 |
$2K |
| A9150 |
Non-prescription drugs |
397 |
306 |
$2K |
| 83880 |
|
108 |
103 |
$762.53 |
| 80061 |
Lipid panel |
41 |
41 |
$698.75 |
| 94760 |
|
154 |
149 |
$617.96 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
41 |
41 |
$512.29 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
25 |
24 |
$479.12 |
| 81003 |
|
353 |
306 |
$410.77 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
187 |
170 |
$312.83 |
| 84439 |
|
32 |
30 |
$304.35 |
| 80305 |
|
14 |
13 |
$227.81 |
| 70450 |
Computed tomography, head or brain; without contrast material |
14 |
12 |
$208.64 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
64 |
58 |
$206.91 |
| 84484 |
|
377 |
324 |
$159.09 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
15 |
$157.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
50 |
43 |
$119.27 |
| 82550 |
|
199 |
182 |
$63.74 |
| 83735 |
|
14 |
12 |
$57.60 |
| 82553 |
|
144 |
135 |
$49.84 |
| J7050 |
Infusion, normal saline solution, 250 cc |
55 |
50 |
$20.86 |
| A4649 |
Surgical supply; miscellaneous |
68 |
57 |
$16.85 |
| 85610 |
|
19 |
19 |
$8.24 |
| 85730 |
|
12 |
12 |
$5.77 |
| J3490 |
Unclassified drugs |
175 |
153 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
82 |
78 |
$0.00 |